New biomarker could flag tumors that are sensitive to common diabetes drug
A newly identified biomarker could help scientists pinpoint which cancers are vulnerable to treatment with biguanides, a common class of medications used to control blood sugar in Type 2 diabetes.
May 19, 2020
0
2